Other: NO intervention ( DrugBank: - )

---

4 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	1
70	Spinal stenosis	1
96	Crohn disease	2
97	Ulcerative colitis	2

13. Multiple sclerosis/Neuromyelitis optica

---

Clinical trials : 3,342 /  Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03001284 (ClinicalTrials.gov)	October 2012	8/12/2016	Multiple Sclerosis Produces Cardiovascular Subclinical Dysfunction		Multiple Sclerosis	Other: NO intervention	Carol Davila University of Medicine and Pharmacy	NULL	Active, not recruiting	18 Years	65 Years	Both	103	N/A	NULL

70. Spinal stenosis

---

Clinical trials : 96 /  Drugs : 203 - (DrugBank : 60) / Drug target genes : 66 - Drug target pathways : 89

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02444351 (ClinicalTrials.gov)	June 26, 2015	28/4/2015	Botulinum Toxin Type A Injection Into the Gastrocnemius Muscle for Treatment of Nocturnal Calf Cramps in Patients With Lumbar Spinal Stenosis		Spinal Stenosis With Nocturnal Calf Cramps	Drug: botulinum toxin type A (Nabota®) injection into the gastrocnemius muscle;Other: no intervention	Yonsei University	NULL	Completed	20 Years	80 Years	All	50	N/A	Korea, Republic of

96. Crohn disease

---

Clinical trials : 2,400 /  Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04617184 (ClinicalTrials.gov)	June 1, 2021	2/11/2020	Registry and Biorepository for IBD in Central Texas	Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas	Crohn Disease;Ulcerative Colitis;Inflammatory Bowel Diseases	Other: NO INTERVENTION	University of Texas at Austin	NULL	Recruiting	18 Years	100 Years	All	1000		United States
2	NCT04898530 (ClinicalTrials.gov)	May 15, 2021	13/5/2021	Diet Patterns in IBD in Central Texas	A Cross-sectional Assessment of Diet in Patients With IBD in Central Texas	Inflammatory Bowel Diseases;Crohn Disease;Ulcerative Colitis	Other: NO INTERVENTION	University of Texas at Austin	NULL	Recruiting	18 Years	N/A	All	500		United States

97. Ulcerative colitis

---

Clinical trials : 2,527 /  Drugs : 1,465 - (DrugBank : 259) / Drug target genes : 144 - Drug target pathways : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04617184 (ClinicalTrials.gov)	June 1, 2021	2/11/2020	Registry and Biorepository for IBD in Central Texas	Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas	Crohn Disease;Ulcerative Colitis;Inflammatory Bowel Diseases	Other: NO INTERVENTION	University of Texas at Austin	NULL	Recruiting	18 Years	100 Years	All	1000		United States
2	NCT04898530 (ClinicalTrials.gov)	May 15, 2021	13/5/2021	Diet Patterns in IBD in Central Texas	A Cross-sectional Assessment of Diet in Patients With IBD in Central Texas	Inflammatory Bowel Diseases;Crohn Disease;Ulcerative Colitis	Other: NO INTERVENTION	University of Texas at Austin	NULL	Recruiting	18 Years	N/A	All	500		United States

Back to top